Viewing Study NCT04213261


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2026-01-31 @ 8:56 PM
Study NCT ID: NCT04213261
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2019-12-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Sponsor: Castle Creek Biosciences, LLC.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recessive Dystrophic Epidermolysis Bullosa View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RDEB View